FOCUS UNIVERSAL INC. 10-K

Item 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES. Market Information On August 31, 2021, the Company commenced the trading of its common stock on the Nasdaq Capital Market under the symbol “FCUV.” From January 28, 2022, to September 22, 2024, the Company’s shares traded on the Nasdaq Global Market. Starting on September 23, 2024, our securities were transferred for trading in the Nasdaq Capital Market. On March 24, 2026, the last reported sale price of our common stock as reported on the Nasdaq Capital Market was $4.58 per share. On September 23, 2014, our common stock was verified for trading on the OTCQB Market under the trading symbol “FCUV.” Prior to that time, there was no public market for our stock. The following table sets forth for the indicated periods the high and low intra-day sales price per share for our common stock on the Nasdaq Global Market and Nasdaq Capital Market (as applicable) for the four quarters of 2024 and 2025. As of September 23, 2024, our common stock trades upon the Nasdaq Capital Market. High Low 2024: First Quarter $ 179.00 $ 34.10 2024: Second Quarter $ 42.79 $ 23.20 2024: Third Quarter $ 47.00 $ 17.89 2024: Fourth Quarter $ 48.50 $ 21.23 2025: First Quarter $ 97.00 $ 33.40 2025: Second Quarter $ 59.80 $ 32.00 2025: Third Quarter $ 41.10 $ 18.20 2025: Fourth Quarter $ 52.50 $ 7.53 Holders As of March 25, 2026, there were 328 record holders of 1,025,135 shares of the Company’s common stock. The number of record holders was determined from the records of our transfer agent and does not include beneficial owners of common stock whose shares are held in the names of various security brokers, dealers, and registered clearing agencies. The transfer agent of our common stock is VStock Transfer, LLC. Dividends The Company has not paid any cash dividends to date and does not anticipate or contemplate paying dividends in the foreseeable future. It is the present intention of management to utilize all available funds for the development of the Company’s business. However, we cannot provide any assurance that we will or will not declare or pay cash dividends on our common stock. Any future determination to declare cash dividends will be made at the discretion of our Board of Directors, subject to applicable laws, and will depend on our financial condition, results of operations, capital requirements, general business conditions and other factors that our Board of Directors may deem relevant. 33 Securities Authorized for Issuance Under Equity Compensation Plans On December 15, 2018, our Board of Directors presented the 2018 Equity Incentive Plan to the shareholders. On December 17, 2018, the holders of 63.051% of our issued and outstanding shares of common stock adopted a resolution by written consent without a meeting adopting the 2018 Equity Incentive Plan. The plan reserves an aggregate of 100,000 shares of the Company’s common stock, which provides for the payment of various forms of incentive compensation to employees, consultants, executives, and directors of the Company. The 2018 Equity Incentive Plan provides for the grant of the following types of stock awards: (i) incentive stock options; (ii) non-statutory stock options; (iii) stock appreciation rights; (iv) restricted stock awards; (v) restricted stock unit awards; and (vi) other stock awards. Under the 2018 Equity Incentive Plan, a ten percent stockholder will not be granted an incentive stock option unless the exercise price of such option is at least one hundred and ten percent of the fair market value on the date of grant and the option is not exercisable after the expiration of five years from the grant date. The Board of Directors determines the vesting schedule of the grants with broad discretion. On August 6, 2019, each member of the Board was granted 450 options to purchase shares at $380.00 per share. On December 11, 2020, each member of the Board was granted 225 options to purchase shares at $200.00 per share. On December 31, 2021, each member of the Board was granted 225 options to purchase shares at $591.00 per share. On December 30, 2022, each member of the Board was granted 225 options to purchase shares at $427.00 per share. On January 2, 2024, each member of the Board was granted 225 options to purchase shares at $150.00 per share. On January 2, 2025, each member of the Board was granted 225 options to purchase shares at $34.55 per share. Recent sales of unregistered securities None. Issuer Purchases of Equity Securities The following table shows the repurchases made in 2024 and 2025. Period (a) Total number of shares (or units) purchased (b) Average price paid per share (or unit) (c) Total number of shares (or units) purchased as part of publicly announced plans or programs (d) Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs October 2024 4,098 $ 25.79 6,729 – November 2024 1,922 $ 25.92 8,651 – December 2024 4,546 $ 27.36 13,197 – January 2025 321 $ 61.12 13,518 – February 2025 20 $ 42.25 13,538 – March 2025 2,826 $ 43.92 16,364 – April 2025 77 $ 18.75 16,441 – June 2025 713 $ 39.00 17,154 – July 2025 1,846 $ 41.07 19,000 – November 2025 2,430 $ 31.03 21,430 – December 2025 8,851 $ 19.13 30,281 – 34 Item 6. [RESERVED]